J.R. Rieger of the Rieger Report Interview of Justin Lowry

J.R. Rieger of the Rieger Report recently interviewed Justin Lowry, President & Chief Investment Officer, of Global Beta Advisors, regarding the current market for yield, how dividends can enhance investors’ income in their portfolio, and identifying the different types of equity dividend strategies.

Hear from Justin Lowry, President & Chief Investment Officer, Global Beta Advisors, as he discusses how to generate income in a low rate environment with Martin Plachko, CIMA, Partner and Head of Distribution at Impact Consulting & Distribution.

Hear from Vince Lowry, Chief Executive Officer of Global Beta Advisors, as he speaks with Fox News Business Hosts, Maria Bartiromo, regarding the markets and his perspective and insight into how price-to-sales and valuations need to be considered during this

Free On-Demand Webinar: Harnessing The Power Of Price-To-Sales

Listen to Vince Lowry, Global Beta Advisor’s CEO, as he shares his insights and perspectives in this informative webinar on using price-to-sales ratios to predict future stock returns. Along with David Armstrong, editor-in-chief of Wealthmanagement.com, Lowry discusses the power of evaluating investments based on price-to-sales multiples, associated research illustrating the correlation between price-to-sales and future returns, and why companies with high price-to-sales multiples must grow their revenues at an exponential rate compared to the rest of the market.

Play the Webinar

Subscribe to Our Newsletter

Subscribe now to receive the latest news & updates.

The misconception that low volatility strategies are simply utilities exposure in disguise has been perpetuated through, what we believe is flawed, low volatility strategies, such as the S&P 500 Low Volatility Index, which selects and weights companies by their individual

As the market navigates what has been historically the two most volatile months of the year in September and October, November is setting up to be a month to remember. Of course, the election is set for November 3rd, Pfizer

The current struggle for investors is to find exposure to growth without paying through the nose for it. It becomes increasingly difficult to satisfy that objective when the economy is trying to come out of a recession and interest